Abstract
Cariprazine is an approved antipsychotic and antidepressant which is a dopamine (DA) D<sub>3</sub>-preferring D<sub>3</sub>/D<sub>2</sub> receptor partial agonist, serotonin (5-HT) 5-HT<sub>1A</sub> receptor partial agonist, and 5-HT<sub>2B</sub> and 5-HT<sub>2A</sub> receptor antagonist, a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have